BioTissue Ocular

Home
United States
Miami, FL
BioTissue Ocular

We develop innovative Amniotic Membrane products for the management of ocular surface diseases.

BioTissue® is the leader in regenerative biologic therapies and ocular hygiene solutions, helping eye care professionals heal ocular surface conditions, such as keratitis, recurrent corneal erosions, conjunctivochalasis dry eye, pterygium and dry eye.

10/30/2025

You didn’t hear it from us… oh wait, yes you did. 👀

10/24/2025

At ASOPRS 2025, we hosted a fantastic dinner with Dr. Alon Kahana, who shared his experience using AmnioGuard® in Oculoplastics.

We got to connect with surgeons about improving outcomes with AmnioGuard and AmnioGraft®.

Thank you to everyone who joined us!

10/22/2025

If you’ve talked to us at AAO, you already know the punchline: early intervention matters.

And if you’re not tired of hearing it yet… we’ll say it louder for the people in the back!!

CAM360 AmnioGraft™ & Prokera® can help you intervene earlier with your patients.

Missed us? Check out our website to speak with our team!

10/21/2025

Eye drops not working like you would have hoped?

Still experiencing dry, irritated eyes that never seem to get better?
Preliminary data has shown CAM360 AmnioGraftTM helped promote improvements in both signs and symptoms within 2 to 3- days in patients with mild to moderate DED..1

Ask your physician if it’s right for you.

1. Short-Term Outcomes Associated with CAM360 AmnioGraft™: Results from Real-World Evidence. BioTissue® Holdings Inc.; 2025. US-CAM360-0110.

10/15/2025

👀Look out for us at AAO!
Here’s a sneak peek of the BioTissue Booth #3109 that you’ll see next week in Orlando.

Time matters. Don’t wait until “next year’s AAO” to start the conversation. Stop by and let’s talk early intervention with Cryopreserved Amniotic Membranes.

Poster:
Effect of Cryopreserved Amniotic Membrane after Corneal Cross-Linking in Keratoconus Patients: A Controlled, Retrospective Study – Melanne Rosetta, OD & Reena Gupta, MD

10/13/2025

Over 1 million clinical applications of Cryopreserved Amniotic Membrane began with a mother’s decision to donate.

This represents the power of generosity and the lasting impact it can have on patient lives.

10/09/2025

Meet Roger, BioTissue®’s Sr. Director of Marketing! He’ll be at AAO in Orlando, ready to talk about our Cryopreserved Amniotic Membrane solutions: CAM360 AmnioGraft ™, Prokera®, AmnioGraft®, & AmnioGuard®.

📍 Stop by Booth #3109!

10/08/2025

Come see us at ASOPRS on Oct 16th -17th to speak with our team!

Learn how AmnioGraft® & AmnioGuard®, Cryopreserved Amniotic Membranes, may help support healing in ocular surface, orbital, and reconstructive procedures.¹

Stop by Booth #306!

1. Finger, P.,T., Jain, P., Mukkamala, S., K., et al. Super-thick Amniotic Membrane for Ocular Surface Reconstruction. Am J Ophthalmol. 2019;Feb:198:45-53. 2. Slentz, D., Nelson, C., Novel Use of Cryopreserved Ultra-thick Human Amniotic Membrane for Management of Anophthalmic Socket Contracture. Ophthalmic Plast Reconstr Surg. 2019;Mar-April:35(2):193-196. 3. Slentz, D., Joseph, S., Nelson, C. The Use of Umbilical Amnion for Conjunctival Socket, Fornix, and Eyelid Margin Reconstruction. Ophthalmic Plast Reconstr Surg. 2020;Jul-Aug:36(4):365-371.

10/07/2025

BioTissue® is taking center stage this October! ✨
From Boston to Orlando, our research at the American Academy of Optometry and American Academy of Ophthalmology will showcase how Cryopreserved Amniotic Membrane is advancing care for complex ocular surface & corneal conditions.

📍 Join us to explore the future of ocular innovation.

10/03/2025

AAO is on Oct 18th – 20th in Orlando! Speak with our team about how CAM360 AmnioGraft™, Prokera®, AmnioGraft®, & AmnioGuard® can support you & your patients.

10/02/2025

Announcing the BioTissue Medical Advisory Board (MAB)

We are proud to partner with this world-renowned team of leaders in Ophthalmology & Optometry who are shaping the future of patient care. Their expertise will help us strengthen clinical best practices & advance regenerative solutions for Ocular Surface
Disease.

With our new MABs insights, BioTissue will remain steadfast to setting the standards that define next-generation regenerative care.

Address

7300 Corporate Center Drive, Suite 700
Miami, FL
33126

Website

http://www.biotissue.com/products/BioTissue-ocular/

Alerts

Be the first to know and let us send you an email when BioTissue Ocular posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Miami?